K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach

Hepato-Gastroenterology

Volumn 46, Issue 27, 1999, Pages 2063-2068

  van Rees, B P ^a,c   Musler, A ^a   Gaspers, E ^a   Drillenburg, P ^a   Craanen, Me ^a   Polkowski, W ^b   Chibowski, D ^b   Offerhaus, Gja ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Carcinoma; Gastric stump; K ras; Stomach

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DNA HYBRIDIZATION; DNA PROBE; DOT HYBRIDIZATION; EPSTEIN BARR VIRUS; FEMALE; GENE MUTATION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH STUMP CARCINOMA;

AGED; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTRIC STUMP; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, VIRAL; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032781969     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Howson CP, Hiyama T, Wynders EL: The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8:27.
2. La Vecchia C, Luccini F, Negri E, Boyle P, Maisonneuve P, Levi F: Trends of cancer mortality in Europe; 1955-1989: I, digestive sites. Eur J Cancer 1992; 28:132-135.
3. Allum WH, Powell DJ, McConkey CC, Fielding JW: Gastric cancer: a 25-year review. Br J Surg 1989; 76:535-540.
4. Akoh JA, Macintyre IM: Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 1992; 79:293-299.
5. Heberer G, Teichmann RK, Kramling HJ, Gunther B: Results of gastric resection for carcinoma of the stomach: the European experience. World J Surg 1988; 12:374-381.
6. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: pathobiological classification. Cancer 1977; 39:2475-2485.
7. Correa P: Precursors of gastric and oesophageal cancers. Cancer 1982; 50:2554-2565.
8. Goldstone AR, Quirke P, Dixon MF: Helicobocter pylori infection and gastric cancer. J Pathol 1996, 179: 129-137.
9. Solcia E, Fiocca R, Luinetti O, et al: Intestinal and diffuse cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20(S1):S8-S22.
10. Caygill CPJ, Hill MJ, Kirkham JS, Northfield TC: Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986; i:929-931.
11. Offerhaus GJ, Tersmette AC, Huibregtse K, et al: Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 post gastrectomy patients. Gut 1988; 29:1588-1590.
12. Tersmette AC, Goodman SN, Offerhaus GJ, et al: Multivariate analysis of the risk of gastric cancer after peptic ulcer surgery in an Amsterdam cohort of post gastrectomy patients. Am J Epidemiol 1991; 134:14-21.
13. Offerhaus GJA, van de Stadt J, Huibregtse K, Tytgat GNJ: Endoscopic screening for malignancy in the gastric remnant. The clinical significance of dysplasia in gastric mucosa. J Clin Pathol 1984; 37:748-754.
14. Offerhaus GJA, van de Stadt J, Huibregtse K, Tersmette AC, Tytgat GNJ: The mucosa of the gastric remnant harboring malignancy. Histological findings in the biopsies of 504 asymptomatic patients 15-46 years after partial gastrectomy with the emphasis on non-malignant lesions. Cancer 1989; 64:698-703.
15. Offerhaus GJA, van de Stadt J, Samson G, Tytgat GNJ: Cell proliferation kinetics in the gastric remnant. Eur J Cancer Res Clin Oncol 1985; 21:73-79.
16. Offerhaus GJA: Gastric stump cancer: lessons from old specimens. Lancet 1984; 343:66-67.
17. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirobashi S: p53 mutation in gastric cancer: a genetic model for carcinogenosis is common to gastric and colorectal cancer. Int J Cancer 1993; 54:759-764.
18. Wright PA, Williams GT: Molecular biology and gastric carcinoma. Gut 1993; 34:145-147.
19. Correa P: A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554-3560.
20. Baas IO, van Rees BP, Musler A, et al: Helicobacter pylori - and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared to carcinoma in the non-operated stomach. J Clin Pathol 1998; 51:662-666.
21. Bos JL: The ras gene family and human carcinogonesis. Mutat Res 1988; 195:255-217.
22. Sigal IS: The ras oncogene: a structure and some function. Nature 1988; 332:485-486.
23. Craanen ME, Blok P, Top B, et al: Absence of ras gene mutations in early gastric carcinomas. Gut 1995; 37:758-762.
24. Hongyo T, Buzard GS, Palli D, et al; Mutations of the K- ras and p53 genes in gastric adenocarcinomas from a high- incidence region around Florence, Italy. Cancer Res 1995; 55:2665-2672.
25. Chung CH, Wilentz RE, Polak MM, et al: Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol 1996; 49:460-464.
26. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR: An evaluation of six antibodies for immunohistochomistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172:5-12.
27. Deng G, Liu XH, Wang J: Correlation of mutations of oncogene c-Ha-ras at codon 12 with metastasis and survival of gastric cancer patients. Oncogene Res 1991; 6:33-38.
28. Dijkhuizen SMM, Entius MM, Clement MJ, et al: Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential. Gastroenterol 1997; 112:561-566.
29. Goelz SE, Hamilton SR, Vogelstein B: Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985; 130:118-126.
30. Craanen ME, Blok P, Dekker W, Offerhaus GJA, Tytgat GNJ: Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995; 36:848-852.
31. Joypaul BV, Newman EL, Hopwood D, et al: Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochcmical study of p53 in gastric carcinoma. Am J Clin Pathol 1994; 101:177-180.
32. Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC, et al: Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach. Cancer 1996; 78:2288-2299.
33. Offerhaus GJA, Rieu PNM, Jansen JBMJ, Joosten HJM, Lamers CBHW: Prospective comparative study of the influence of bile reflux on human mucosal histology and Campylohacter pylori infection. Gut 1989; 30:1552-1557.
34. Harn HJ, Chang JY, Wang MW, et al: Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Human Pathol 1995; 26:267-271.
35. Tokunuga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E: Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993; 143:1250-1254.
36. Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG: EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, hinds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 1993; 90:5455-5459.
37. Gulley ML, Burton MP, Allred DC, et al: Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Human Pathol 1998; 29:252-259.